Table II.

Comparison of anthropometric data between SH patients: non-treated (SH-T0) and treated with levothyroxine (SH-T1)

Parameter	SH (n= 130) Mean ± SD (median; IQR)	SH-T0 (n= 35) Mean ±SD (median; IQR)	SH-T1 (n= 95) Mean ±SD (median; IQR)	p-value (* significance between SH-T0 and SH-T1)
hSDS at baseline	–0.1 ±1.6 (0.0; from –1.2 to 1.0)	–0.3 ±1.4 (–0.4; from –1.4 to 0.6)	0.0±1.7 (0.2; from –1.1 to 1.2)	0.315
ΔhSDS	0.0±0.7 (0.1; from –0.3 to 0.5)	0.1 ±0.9 (0.2; from –0.2 to 0.4)	0.0 ±0.8 (0.1; from –0.3 to 0.5)	0.843
BMI Z-score at baseline	0.3 ±1.3 (0.2; from –0.9 to 1.3)	0.2 ±1.2 (0.2; from –0.5 to 1.0)	0.3 ±1.4 (0.3; from –0.9 to 1.4)	0.769
ΔBMI Z-score	0.0±0.6 (–0.1; from –0.4 to 0.2)	0.0 ±0.5 (0.0; from –0.4 to 0.3)	0.0 ±0.7 (0.1; from –0.4 to 0.2)	0.761

hSDS – height standard deviation score; BMI – body mass index; N – number; SD – standard deviation